CHERISE L MIZRAHI-LEVI
Allopathic & Osteopathic Physicians|Dermatology WILTON MANORS, FL NPI 1649550591
Browse related groups: Allopathic & Osteopathic Physicians|Dermatology FL Acerta Pharma LLC All categories
General Payments — all program years on this page
$1,498.49
- Category: General Payments
- Program years: PY2018–2024
- Record count: 67
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $290.70 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $290.70 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $121.10 | 1 |
| Almirall LLC | $82.76 | 4 |
| Biofrontera Inc. | $37.95 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $28.23 | 1 |
| GENZYME CORPORATION | $20.66 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1087132952 | Novartis Pharmaceuticals Corporation | $28.23 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1092760223 | Biofrontera Inc. | $19.76 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1103323414 | Biofrontera Inc. | $18.19 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105290649 | AstraZeneca Pharmaceuticals LP | $121.10 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1120644557 | Almirall LLC | $27.61 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1120644571 | Almirall LLC | $16.18 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1120644583 | Almirall LLC | $25.86 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1120644617 | Almirall LLC | $13.11 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139973667 | GENZYME CORPORATION | $20.66 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.